Techniques for Glycol Nanohydrogel Development
Glycol nanohydrogel is an adaptable and versatile biomaterial with nanoscale dimensions, comprising natural and synthetic polymers or their blends. Its smaller size and superior performance, compared to larger hydrogels and other types, render it ideal for stimuli-responsive drug delivery and various other applications. CD BioGlyco has established the robust GlycoNano™ Platform, providing a comprehensive glycol nanohydrogel development service that encompasses synthesis, purification, and characterization. This service is grounded in a broad spectrum of methodologies tailored to meet clients' research needs.
Advanced and Customizable Glycol Nanohydrogel Development Service
Drawing from our extensive experience in Developing Glycol Nanohydrogel, we employ diverse techniques to synthesize a range of glycol nanohydrogels tailored for specific attributes such as stability and responsiveness. We meticulously consider factors including surface properties, application scope, functional groups, and degradability, ensuring optimal process refinement. Here's an overview of our service:
Precipitation Polymerization-based Glycol Nanohydrogel Development
We dissolve the monomer and crosslinker in the reaction medium water. In the presence of an initiator, the polymer chains generated during the polymerization process grow to a certain length and then phase separation occurs to form polymer colloidal particles and further cross-linking structures, resulting in nanohydrogels.
Inverse Emulsion Polymerization-based Glycol Nanohydrogel Development
In this method, monomers and crosslinkers are dispersed in the organic solvent in the presence of the oil-soluble emulsifier to make an inverse emulsion using an appropriate emulsification method (e.g., mechanical stirring emulsification, homogeneous emulsification, membrane emulsification, or microfluidic emulsification, etc.). The polymerization of the monomer and crosslinker is then initiated, and the nanohydrogels are finally obtained by removing the organic solvent and emulsifier. We have optimized the entire synthesis process to ensure that glycol nanohydrogel is of high quality and suitable for specific research purposes.
Microtemplate-assisted Polymerization-based Glycol Nanohydrogel Development
We first add the aqueous solution of monomer and crosslinker to the microtemplate, and then the monomer and crosslinker in the microtemplate undergo the free radical polymerization reaction by chemical initiation or photoinitiation. The formed glycol nanohydrogel is separated from the micro template. This method has more advantages, including the ability to prepare nanohydrogels with different shapes, and relatively easy encapsulation of cells or other bioactive components.
Precipitation/Crosslinking-based Glycol Nanohydrogel Development
We precipitate certain water-soluble polymers from the homogeneous aqueous solution to form nanoparticles by heating, pH adjustment, or ionic strength. Then, the cross-linking reaction such as chemical cross-linking or photocross-linking is used to produce a cross-linking structure of the polymers within the particles to produce glycol nanohydrogel.
Emulsion/Crosslinking-based Glycol Nanohydrogel Development
In this method, the polymer used to synthesize glycol nanohydrogel is first dispersed in the organic solution using the oil-soluble surfactant to make the W/O inverse emulsion. Then the water-soluble crosslinking is added to make a cross-linking reaction between the polymers. After removing the organic solvent and surfactant, the glycol nanohydrogel stably dispersed in water is finally obtained. This method is also suitable for the synthesis of nanohydrogel with small particle sizes.
Self-assembly/Crosslinking-based Glycol Nanohydrogel Development
Molecular self-assembly is the process by which molecules spontaneously form thermodynamically stable aggregates with a well-defined ordered structure through non-covalent bonding interactions (hydrogen bonding interactions, electrostatic interactions, hydrophobic interactions, van der Waals forces, etc.). Water-soluble polymers with a specific structure form well-stabilized glycol nanohydrogels driven by these weak interactions and combined with methods such as chemical crosslinking or photocrosslinking, etc. This method is suitable for the preparation of natural polymer-based and graft-modified glycol nanohydrogels under mild conditions.
Microtemplating/Crosslinking-based Glycol Nanohydrogel Development
We add the polymer precursors for the formation of nanohydrogels into the micro templates, and then the glycol nanohydrogel is finally produced by chemical cross-linking, photo-cross-linking, etc. The synthesis parameters of the whole process are optimized to ensure.
Workflow
We customize glycol nanohydrogel based on composition/structure, synthetic method, stimulation reactivity, application, etc. The development process of glycol nanohydrogel includes the following and the synthesis, purification, and freeze-drying parameters are optimized.

Preparation of Glycol nanohydrogel
A wide variety of monomers are available, including natural products and synthetic polymers. We choose the appropriate method for the preparation.
Natural Polymer-based Glycol Nanohydrogel Production Service
We synthesize glycol nanohydrogel by utilizing abundant natural polymers, including glycoproteins (collagen, gelatin), Carbohydrates (agarose, starch, etc.), glycosaminoglycans (hyaluronic acid, chondroitin sulfate), and so on.
Learn More
Synthetic Polymer-based Glycol Nanohydrogel Production Service
A wide variety of synthetic polymers including Polylactic Acid (PLA), Polyvinyl Alcohol (PVA), etc., are used to synthesize glycol nanohydrogel. We provide a one-stop glycol nanohydrogel production service.
Learn More
Purification of Glycol nanohydrogel
This process involves the purification of glycol nanohydrogel by centrifugation or dialysis to remove unreacted material and other impurities. The entire purification process has been optimized to ensure the quality of the glycol nanohydrogel.
Characterization of Glycol nanohydrogel
We use dynamic light scattering, scanning electron microscopy (SEM), transmission electron microscopy (TEM), and other technologies to analyze the shape, size, mechanical properties, swelling rate, biocompatibility, electrochemical behavior, etc., of the glycol nanohydrogel.
Applications
- The developed glycol nanohydrogel has potential applications in drug delivery in anti-inflammatory therapies, cancer therapies, anti-viral therapies, anti-diabetic therapies, and other therapies.
- The developed glycol nanohydrogel is also used for bioimaging applications of different molecules.
- The developed glycol nanohydrogel has good applications in the biomedical detection of ions, bioactive small molecules, proteins, and others.
Advantages
- Research experience in a wide range of glycol nanohydrogel synthesis methods ensures that we meet our client's needs precisely.
- We combine various analytical techniques to quickly, accurately, and efficiently characterize the structure and properties of the developed glycol nanohydrogel.
- We provide our clients with comprehensive research support, including detailed explanation of experimental methods, detailed analysis of results, and recommendations for follow-up studies.
Publication Data
Technologies: Self-assembly/crosslinking, SEM, TEM
Journal: Pharmaceutics
IF: 4.421
Published: 2019
Results: In this study, a polysaccharide-based nanohydrogel was constructed by a self-assembly/crosslinking method. The researchers obtained a cationic derivative of pullulan polysaccharide through a grafting reaction and formed a crosslinked nanohydrogel together with dextran sulfate. The nanohydrogel is colloidally stabilized and the size and surface charge can be controlled by the polycation/polyanion ratio. Observation of the morphology of the nanohydrogel by SEM and TEM revealed that the resulting structure was spherical with a hydrodynamic diameter in the range of 100-150 nm. Upon binding with cationic branched starch, the nanohydrogel could effectively encapsulate the drug and release it in a controlled manner.
Fig.1 Preparation flow of polysaccharide-based nanohydrogel. (Lachowicz, et al., 2019)
Frequently Asked Questions
- Is this service customizable or able to meet specific research needs?
Absolutely! We understand the uniqueness of each research project and are committed to meeting the individual needs of each client and providing customized solutions. Before the start of the project, we will have in-depth communication and consultation with our clients on the details of the experiments, data analysis, and interpretation of the results, to ensure that the final experimental plan accurately matches your expectations and actual needs. -
How to keep in touch and communicate with our service team?
We attach great importance to communication with our clients, and for each project, we have a dedicated staff responsible for interfacing with our clients and responding quickly to questions and requests. In addition, our diversified communication channels, including phone calls, emails, and online meetings, ensure that we get in touch with our clients anytime, anywhere.
At CD BioGlyco, our customized glycol nanohydrogel development service provides strong support for accelerated research in the areas of targeted drug delivery, biosensors, and medical diagnostics for our clients. Please feel free to contact us if you are interested in our glycol nanohydrogel development services. We are looking forward to cooperating with you to promote the development of nanohydrogel.
Reference
- Lachowicz, D.; et al. Nanohydrogels based on self-assembly of cationic pullulan and anionic dextran derivatives for efficient delivery of piroxicam. Pharmaceutics. 2019, 11(12): 622.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





